Green Cross Holdings Corporation

Informe acción KOSE:A005250

Capitalización de mercado: ₩710.1b

Green Cross Holdings Resultados de beneficios anteriores

Pasado controles de criterios 0/6

Los beneficios de Green Cross Holdings han disminuido a una tasa media anual de -24.2%, mientras que en la industria Biotechs los beneficios crecieron en un 9.2% anualmente. Los ingresos han ido creciendo a una tasa media de 8% al año.

Información clave

-50.5%

Tasa de crecimiento de los beneficios

-50.5%

Tasa de crecimiento del BPA

Crecimiento de la industria Biotechs 11.7%
Tasa de crecimiento de los ingresos7.9%
Rentabilidad financiera-6.1%
Margen neto-3.6%
Última actualización de beneficios30 Jun 2024

Actualizaciones de resultados anteriores recientes

We're Not So Sure You Should Rely on Green Cross Holdings's (KRX:005250) Statutory Earnings

Jan 12
We're Not So Sure You Should Rely on Green Cross Holdings's (KRX:005250) Statutory Earnings

Recent updates

Is Green Cross Holdings (KRX:005250) Using Debt Sensibly?

Aug 09
Is Green Cross Holdings (KRX:005250) Using Debt Sensibly?

Know This Before Buying Green Cross Holdings Corporation (KRX:005250) For Its Dividend

Apr 28
Know This Before Buying Green Cross Holdings Corporation (KRX:005250) For Its Dividend

Is Now The Time To Put Green Cross Holdings (KRX:005250) On Your Watchlist?

Mar 21
Is Now The Time To Put Green Cross Holdings (KRX:005250) On Your Watchlist?

Green Cross Holdings (KRX:005250) Seems To Be Using A Lot Of Debt

Mar 01
Green Cross Holdings (KRX:005250) Seems To Be Using A Lot Of Debt

If You Had Bought Green Cross Holdings (KRX:005250) Stock A Year Ago, You Could Pocket A 106% Gain Today

Feb 12
If You Had Bought Green Cross Holdings (KRX:005250) Stock A Year Ago, You Could Pocket A 106% Gain Today

Here's What Green Cross Holdings Corporation's (KRX:005250) Shareholder Ownership Structure Looks Like

Jan 28
Here's What Green Cross Holdings Corporation's (KRX:005250) Shareholder Ownership Structure Looks Like

We're Not So Sure You Should Rely on Green Cross Holdings's (KRX:005250) Statutory Earnings

Jan 12
We're Not So Sure You Should Rely on Green Cross Holdings's (KRX:005250) Statutory Earnings

Green Cross Holdings Corporation (KRX:005250) Investors Should Think About This Before Buying It For Its Dividend

Dec 28
Green Cross Holdings Corporation (KRX:005250) Investors Should Think About This Before Buying It For Its Dividend

Green Cross Holdings Corporation's (KRX:005250) Financials Are Too Obscure To Link With Current Share Price Momentum: What's In Store For the Stock?

Dec 13
Green Cross Holdings Corporation's (KRX:005250) Financials Are Too Obscure To Link With Current Share Price Momentum: What's In Store For the Stock?

Green Cross Holdings (KRX:005250) Use Of Debt Could Be Considered Risky

Nov 28
Green Cross Holdings (KRX:005250) Use Of Debt Could Be Considered Risky

Optimistic Investors Push Green Cross Holdings Corporation (KRX:005250) Shares Up 63% But Growth Is Lacking

Nov 28
Optimistic Investors Push Green Cross Holdings Corporation (KRX:005250) Shares Up 63% But Growth Is Lacking

Desglose de ingresos y gastos

Cómo gana y gasta dinero Green Cross Holdings. Basado en los últimos beneficios reportados, en base a los últimos doce meses (LTM).

Historial de beneficios e ingresos

KOSE:A005250 Ingresos, gastos y beneficios (KRW Millions)
FechaIngresosBeneficiosGastos G+AGastos de I+D
30 Jun 242,113,064-75,257428,947162,912
31 Mar 242,089,633-68,156426,954168,083
31 Dec 232,057,936-53,448419,632179,470
30 Sep 232,022,765-4,467426,537196,019
30 Jun 232,034,7386,689418,055204,932
31 Mar 232,015,4899,763416,239208,850
31 Dec 222,079,56033,457408,479193,945
30 Sep 222,080,21014,585401,716184,627
30 Jun 222,057,37232,002395,429177,894
31 Mar 221,997,19739,712388,835154,316
31 Dec 211,840,55954,901376,468147,282
30 Sep 211,839,7429,620361,495147,785
30 Jun 211,775,10029,238347,233135,340
31 Mar 211,722,66565,565319,163141,602
31 Dec 201,719,32660,806301,464143,311
30 Sep 201,612,25396,771270,036128,912
30 Jun 201,540,22072,006251,017127,916
31 Mar 201,488,62448,269225,374127,162
31 Dec 191,493,58942,741221,067126,347
30 Sep 191,492,85229,228222,126122,954
30 Jun 191,496,67718,310221,204124,867
31 Mar 191,551,002-222227,157124,320
31 Dec 181,548,71518,465221,863122,405
30 Sep 181,519,20826,751204,758119,275
30 Jun 181,522,76638,297198,275115,068
31 Mar 181,494,55059,556191,544108,345
31 Dec 171,465,48943,364185,640103,749
30 Sep 171,479,23562,679178,320108,474
30 Jun 171,433,08455,552173,950109,047
31 Mar 171,397,33150,325175,393110,624
31 Dec 161,354,46647,177172,994109,210
30 Sep 161,272,15725,266174,099109,676
30 Jun 161,224,59547,651167,153101,413
31 Mar 161,169,78157,849159,51297,034
31 Dec 151,132,87765,421154,01595,507
30 Sep 151,106,56366,458148,70083,567
30 Jun 151,093,49364,003149,36280,311
31 Mar 151,057,32252,063144,30375,281
31 Dec 141,044,76856,761141,52975,014
30 Sep 141,030,19454,428134,89974,901
30 Jun 141,006,09543,922128,92676,938
31 Mar 14973,48643,473125,95675,662
31 Dec 13938,29843,550123,46972,961

Ingresos de calidad: A005250 actualmente no es rentable.

Margen de beneficios creciente: A005250 actualmente no es rentable.

Análisis del flujo de caja libre vs. Beneficios

Análisis del crecimiento de los beneficios en el pasado

Tendencia de beneficios: A005250 no es rentable, y las pérdidas han aumentado en los últimos 5 años a un ritmo de 24.2% al año.

Acelerando crecimiento: No se puede comparar el crecimiento de los beneficios de A005250 en el último año con su promedio de 5 años, ya que actualmente no es rentable.

Beneficios vs. Industria: A005250 no es rentable, por lo que resulta difícil comparar el crecimiento de sus beneficios en el último año con el de la industria Biotechs (28.8%).

Rentabilidad financiera

Alta ROE: A005250 tiene una rentabilidad financiera negativa (-3.81%), ya que actualmente no es rentable.

Rentabilidad económica

Rendimiento del capital invertido

Descubre empresas con buenos resultados en el pasado

7D

1Y

7D

1Y

7D

1Y